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n 2012, the American Contact Dermatitis Society (ACDS) published a core allergen series. 1 The goal of this series was to assist in logically expanding patch testing allergen series beyond the TRUE Test (TT; SmartPractice, Phoenix, Ariz) standard allergens, currently with 34 allergens and 1 negative control. Allergens 36Y39 and 4 subsequent panels of 10 allergens are presented. The goal of the core allergen series is not to produce an '' ACDS 80'' allergen series to be used on every single patient but to give patch testers who are currently using the TT as their baseline series a logical and graded tool to increase the number of allergens tested. This hopefully will increase the yield of relevant and useful positive tests for our patients.
After 4 years of use, we feel that updating the ACDS Core Allergen Series is necessary. The first 35 allergens are primarily based on the TT panels 1.3, 2.3, and 3.3. Since 2012, TT has updated their allergen series, changing the order of allergens tested as well as making changes in the standard allergens tested. We have chosen to substitute allergens in some cases for those not using the TT in the first 35 allergens and updated our additional recommended allergens in allergens 36Y80. The updated panels 1 through 8 of the ACDS Core Allergen Series are presented inTable 1. The changes from the 2012 Core Allergen Series are summarized in detail in Table 2 .
In 2012, we recommended replacing several allergens for those not using TT. Caine mix was replaced with lidocaine, benzocaine, and dibucaine. Thimerosal (TT #23) and quinoline mix (TT #26) were replaced with 2-bromo-2-nitropropane-1,3-diol and benzocaine, respectively. We do not feel that a negative control is necessary.
From the new TT series, we are removing dibucaine (2012 allergen #9) and moving methylisothiazolinone into its place. TRUE Test tests parthenolide (TT #34) routinely. When testing with a more extended series, the screening substances sesquiterpene lactone mix (#57) and compositae mix II (#65) cover parthenolide, and thus, we recommend its optional removal to allow for other allergens in its place.
In addition to the TT changes, 3 allergens were removed. Glutaraldehyde was not felt to be a high-yield allergen. Even though jasmine and lavender have similar rates of contact allergy, contact allergy to lavender is more frequently reported in the literature, thus the removal of jasmine. 2, 3 Triclosan is a chlorophenolbased biocide used in consumer soaps/washes and in some oral hygiene products. At baseline, it is an infrequent allergen, although it was included in 2012 because of its extensive use in the United States. 4 Triclosan was recently prohibited from use in consumer antiseptic washes, effective in September 2017, by the United States Food and Drug Administration. 5 This should lower the prevalence of allergy from triclosan even further.
The group decided to replace the open slots on the tray with 5 new allergens: polymyxin B sulfate 3% petrolatum (pet) at #39, lavender absolute 2% pet at #47, sodium benzoate 5.0% pet at #62, ethylhexyl glycerin 5.0% pet at #70, and benzoic acid 5% pet at #77. Each of these additions will be considered briefly hereafter.
Polymyxin B is an antibiotic, which is found commonly in topical antibiotic ointments and creams. Patients commonly refer to ''triple antibiotic'' that, in addition to polymyxin B, includes the allergens bacitracin and neomycin. In its own right, polymyxin B is an allergen, and in a recent series of 795 patients, it had a prevalence of 2.3%. 6 The commercial allergen is available from allergEAZE (SmartPractice, Calgary, Alberta, Canada).
Lavender oil is derived from the plant Lavandula angustifolia. It is added to personal care products because of its light floral scent. In addition to fragrant properties, it also has antimicrobial properties as well as many other less proven traditional/alternative uses.
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Rates of allergy were reported to be between 1.1% and 13.9% for an 8-year period, with an overall prevalence of 3.7% in a Japanese study. 8 Lavender is available from Chemotechnique (Vellinge, Sweden) as lavender absolute 2% pet and from allergEAZE as L. angustifolia oil (lavender oil) 2% pet.
Sodium benzoate and benzoic acid are related chemicals, with both preservative and fragrant properties. Benzoic acid is naturally found in many fruits as well as having extensive industrial synthesis. Sodium benzoate is produced synthetically by adding ''natural'' benzoic acid to sodium hydroxide. Potassium and calcium benzoate are closely related salts of benzoic acid. They are commonly added to acidic food and beverages (benzoic acid [E210], sodium benzoate [E211]), as preservatives, having bactericidal properties as well as mold and yeast inhibition. In addition to causing allergic contact dermatitis, cutaneous contact may produce nonimmunologic contact urticaria limited to the skin. 9 Sodium benzoate 5.0% pet and benzoic acid 5% pet are available from Chemotechnique and allergEAZE.
Ethylhexylglycerin is a recently introduced synthetic emollient and antimicrobial, derived from plants/grains. 10 It is used in cosmetics and personal care products as an alternative preservative, replacing parabens. Allergy rates are still low, but its use is increasing. The North American Contact Dermatitis Group added it to their tray for testing in 2014. 11 Ethylhexylglycerin 5.0% pet is available from Chemotechnique.
It is our goal to recommend useful and appropriate testing recommendations for evaluation of our suspected dermatitis patients. Using the ACDS Core Allergen Series will allow the clinician to extend the patch test screening logically to incorporate common, rare, and emerging allergens. 
